Evidence map›Paper›PMID 30271154›Full record

ArticleNeuropsychiatric disease and treatment2018

Low hedonic tone and attention-deficit hyperactivity disorder: risk factors for treatment resistance in depressed adults.

Tia Sternat, Kathryn Fotinos, Alexa Fine, Irvin Epstein, Martin A Katzman

Open access · goldAbstract read
In one paragraph

Article in Neuropsychiatric disease and treatment, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Understanding antidepressant change patterns in the UK Biobank.The British journal of psychiatry : the journal of mental science · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tia SternatSTART Clinic for Mood and Anxiety Disorders, Toronto, ON, Canada, mkatzman@startclinic.ca.
Kathryn FotinosSTART Clinic for Mood and Anxiety Disorders, Toronto, ON, Canada, mkatzman@startclinic.ca.
Alexa FineSTART Clinic for Mood and Anxiety Disorders, Toronto, ON, Canada, mkatzman@startclinic.ca.
Irvin EpsteinSTART Clinic for Mood and Anxiety Disorders, Toronto, ON, Canada, mkatzman@startclinic.ca.
Martin A KatzmanSTART Clinic for Mood and Anxiety Disorders, Toronto, ON, Canada, mkatzman@startclinic.ca.
START Clinic · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe burdens imposed by treatment-resistant depression (TRD) necessitate the identification of predictive factors that may improve patient treatment and outcomes. Because depression and attention-deficit hyperactivity disorder (ADHD) are frequently comorbid and share a complex relationship, we hypothesized that ADHD may be a predictive factor for the diagnosis of TRD. This exploratory study aimed to determine the percentage of undetected ADHD in those with TRD and evaluate factors associated with treatment resistance and undetected ADHD in depressed patients. SUBJECTS AND

methodsAdults referred (n=160) for psychiatric consultation completed a structured interview (MINI Plus, Mini International Neuropsychiatric Interview Plus) to assess the presence of psychiatric disorders.

resultsTRD was significantly associated with the number of diagnoses (

conclusionUndetected ADHD may be more prevalent among TRD patients than previously thought. In addition, TRD patients are more likely to present with psychiatric comorbidity than non-TRD patients. Screening patients with depression for the presence of ADHD and chronic anhedonia/low hedonic tone may help identify patients with TRD and undetected ADHD and improve treatment outcomes.

Indexed as

anhedoniaattentioncatecholaminedopaminedrug responsesuicide

Identifiers

PMID30271154
PMCPMC6149933
OpenAlexW2891064073

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.